Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (6)

« Back to Publications

Correspondence on "Parents' perceptions of the utility of genetic testing in the NICU" by Callahan et al.

Sansom SL. et al, (2026), Genet Med, 28

Measuring patient- and carer-reported outcomes following genome sequencing for rare disease diagnosis: a psychometric assessment of outcome measurement instruments

Sansom S. et al, (2025), Value in Health, 28

Making progress with newborn screening

Lucassen ANNEKE. et al, (2025)

Estimating the impact of Angelman syndrome on parental productivity in Australia using productivity-adjusted life years.

Sansom SL. et al, (2023), Disabil Health J, 16

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.

Morgan A. et al, (2021), Eur J Health Econ, 22, 505 - 518

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.

Schattenberg JM. et al, (2021), Liver Int, 41, 1227 - 1242